{"id":460453,"date":"2023-05-11T22:05:17","date_gmt":"2023-05-12T05:05:17","guid":{"rendered":"https:\/\/nai500.com\/?p=460453"},"modified":"2023-05-11T22:05:17","modified_gmt":"2023-05-12T05:05:17","slug":"%e6%9c%ac%e5%91%a8%e7%be%8e%e8%82%a1%e6%88%90%e9%95%bf%e8%82%a1%e9%ab%98%e6%ad%8c%e7%8c%9b%e8%bf%9b-3%e5%8f%aa%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e8%82%a1","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2023\/05\/%e6%9c%ac%e5%91%a8%e7%be%8e%e8%82%a1%e6%88%90%e9%95%bf%e8%82%a1%e9%ab%98%e6%ad%8c%e7%8c%9b%e8%bf%9b-3%e5%8f%aa%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e8%82%a1\/","title":{"rendered":"\u672c\u5468\u7f8e\u80a1\u6210\u957f\u80a1\u9ad8\u6b4c\u731b\u8fdb\uff0c\u5c24\u5176\u662f\u8fd93\u53ea\u751f\u7269\u5236\u836f\u80a1\u7968"},"content":{"rendered":"<p>\u867d\u7136\u6d88\u8d39\u8005\u4ef7\u683c\u6307\u6570\uff08CPI\uff09\u518d\u6b21\u4e0d\u5982\u4eba\u610f\uff0c\u533a\u57df\u94f6\u884c\u80a1\u7968\u7684\u6ce2\u52a8\u52a0\u5927\uff0c\u4f46\u6574\u4f53\u6765\u8bf4\uff0c\u7f8e\u56fd\u80a1\u5e02\u7684\u6210\u957f\u578b\u80a1\u7968\u672c\u5468\u4f9d\u7136\u7ef4\u6301\u4e0a\u5347\u8d8b\u52bf\u3002\u6bd4\u5982\u8bf4\uff0c\u672c\u5468\u524d3\u4e2a\u534a\u4ea4\u6613\u65e5\u5f53\u4e2d\uff0c\u7eb3\u65af\u8fbe\u514b\u7efc\u5408\u6307\u6570\u4e0a\u6da8\u8fd13%\uff0c\u5176\u4e2d\u6da8\u52bf\u6700\u731b\u7684\u662f\u751f\u7269\u5236\u836f\u80a1\u7968\u3002<\/p>\n<p>\u5177\u4f53\u6765\u770b\uff0c\u540c\u671f\u57fa\u56e0\u7f16\u8f91\u6807\u6746\u516c\u53f8<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=CRSP\">CRISPR Therapeutics AG\uff08NASDAQ:CRSP\uff09<\/a>\u7684\u80a1\u4ef7\u5927\u6da824.6%\uff0c\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u836f\u54c1\u5f00\u53d1\u516c\u53f8BioXcel Therapeutics Inc\uff08NASDAQ:BTAI\uff09\u7684\u80a1\u4ef7\u4e0a\u6da819.8%\uff0c\u57fa\u56e0\u533b\u836f\u516c\u53f8Verve Therapeutics Inc\uff08NASDAQ:VERV\uff09\u4e0a\u6da811%\u3002<\/p>\n<h2>\u8fd93\u53ea\u751f\u7269\u5236\u836f\u80a1\u7968\u4e3a\u4f55\u5927\u6da8\uff1f<\/h2>\n<p>CRISPR\u8054\u624b\u798f\u6cf0\u5236\u836fVertex Pharmaceuticals\uff08NASDAQ:VRTX\uff09\u5f00\u53d1\u7684\u8840\u6db2\u75c5\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5exa-cel\u76ee\u524d\u6b63\u5728\u5ba1\u6279\u8fc7\u7a0b\u4e2d\uff0c\u4e00\u65e6\u83b7\u6279\uff0c\u5546\u4e1a\u524d\u666f\u53ef\u89c2\uff0c\u56e0\u6b64\u8fd9\u53ea\u751f\u7269\u5236\u836f\u80a1\u7968\u7684\u4ef7\u683c\u4e00\u76f4\u5728\u7a33\u6b65\u4e0a\u6da8\u3002<\/p>\n<p>\u81f3\u4e8eBioXcel Therapeutics\uff0c\u672c\u5468\u8be5\u516c\u53f8\u53d1\u5e03\u7684\u4e00\u5b63\u62a5\u6574\u4f53\u79ef\u6781\uff0c\u5176\u4e2d\u7684\u4eae\u70b9\u662f\u8be5\u751f\u7269\u79d1\u6280\u516c\u53f8\u6700\u91cd\u8981\u7684\u4ef7\u503c\u9a71\u52a8\u529bBXCL501\u3002\u5177\u4f53\u6765\u8bf4\uff0c\u8be5\u516c\u53f8\u9884\u8ba1\u5c06\u5728\u672a\u6765\u51e0\u4e2a\u6708\u5185\u53d1\u5e03\u8be5\u836f\u7269\u6cbb\u7597\u8bf8\u5982\u91cd\u5ea6\u6291\u90c1\u75c7\u4ee5\u53ca\u7cbe\u795e\u5206\u88c2\u75c7\u76f8\u5173\u6fc0\u8d8a\u7b49\u591a\u4e2a\u9ad8\u4ef7\u503c\u9002\u5e94\u75c7\u7684\u8bd5\u9a8c\u9876\u7ebf\u7ed3\u679c\u3002\u5982\u679c\u4e00\u5207\u6309\u7167\u8ba1\u5212\u63a8\u8fdb\uff0cBioXCel\u5c06\u62e5\u6709\u771f\u6b63\u7684\u836f\u7269\u3002<\/p>\n<p>\u9664\u4e86\u5ba3\u5e03\u53c2\u52a05\u670816\u65e5\uff08\u5468\u4e8c\uff09\u4e3e\u884c\u7684RBC Capital Markets 2023\u5e74\u5168\u7403\u533b\u7597\u5927\u4f1a\u4e4b\u5916\uff0cVerve\u672c\u5468\u5e76\u6ca1\u6709\u53d1\u5e03\u4ec0\u4e48\u6d88\u606f\uff0c\u56e0\u6b64\u8fd9\u53ea\u57fa\u56e0\u7ec4\u533b\u5b66\u516c\u53f8\u80a1\u4ef7\u7684\u4e0a\u6da8\u57fa\u672c\u5c31\u662f\u8ddf\u968fCRISPR\u53ca\u5176\u4ed6\u57fa\u56e0\u7597\u6cd5\u516c\u53f8\u7684\u4e0a\u6da8\u3002<\/p>\n<p>\u603b\u7684\u6765\u8bf4\uff0c\u5728\u7ecf\u53862022\u5e74\u718a\u5e02\u5927\u5e45\u56de\u64a4\u540e\uff0c\u57fa\u56e0\u7f16\u8f91\u80a1\u7968\u7684\u4ef7\u683c\u4eca\u5e74\u4e00\u76f4\u5728\u53cd\u5f39\u3002\u591a\u5bb6\u516c\u53f8\u5373\u5c06\u5ba3\u5e03\u8be5\u9886\u57df\u7684\u91cd\u5927\u91cc\u7a0b\u7891\uff0c\u8fd9\u5438\u5f15\u6295\u8d44\u8005\u91cd\u73b0\u56f4\u7ed5\u5230\u8fd9\u4e9b\u80a1\u4ef7\u5df2\u7ecf\u5927\u8dcc\u7684\u80a1\u7968\u5468\u56f4\u3002<\/p>\n<h2>\u8fd9\u4e9b\u70ed\u95e8\u7684\u7eb3\u6307\u80a1\u7968\u8fd8\u503c\u5f97\u4e70\u5165\u5417\uff1f<\/h2>\n<p>\u5728\u8fd93\u53ea\u751f\u7269\u5236\u836f\u80a1\u7968\u5f53\u4e2d\uff0cCRISPR\u8131\u9896\u800c\u51fa\uff0c\u4f9d\u636e\u5305\u62ec\u8be5\u516c\u53f8\u62e5\u6709\u8fd120\u4ebf\u7f8e\u5143\u7684\u73b0\u91d1\uff0c\u8fc5\u901f\u6210\u957f\u7684\u514d\u75ab\u80bf\u7624\u548c\u7f55\u89c1\u75c5\u5728\u7814\u836f\u7269\u7ba1\u7ebf\uff0c\u4ee5\u53ca\u8be5\u516c\u53f8\u4e0e\u798f\u6cf0\u5236\u836f\u7684\u5408\u4f5c\u53ef\u4ee5\u5927\u5927\u51cf\u8f7bexa-cel\u7b49\u65b0\u836f\u4e0a\u5e02\u7684\u538b\u529b\u3002<\/p>\n<p>\u4f46\u662f\uff0c\u8fd9\u5e76\u4e0d\u610f\u5473\u7740BioXcel\u548cVerve\u4e0d\u4f1a\u6210\u529f\uff0c\u800c\u662f\u8bf4\u8fd9\u4e24\u5bb6\u516c\u53f8\u8fd8\u9700\u8981\u66f4\u52a0\u52aa\u529b\u5730\u5411\u5b83\u4eec\u7684\u80a1\u4e1c\u8bc1\u660e\u81ea\u5df1\u7684\u6838\u5fc3\u4ef7\u503c\u4e3b\u5f20\u3002\u76f8\u6bd4\u4e4b\u4e0b\uff0cCRISPR\u6709\u53ef\u80fd\u5373\u5c06\u6210\u4e3a\u7b2c\u4e00\u5bb6\u5c06\u57fa\u56e0\u7f16\u8f91\u4ea7\u54c1\u4e0a\u5e02\u7684\u516c\u53f8\u3002<\/p>\n<p><audio style=\"display: none;\" controls=\"controls\"><\/audio><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u867d\u7136\u6d88\u8d39\u8005\u4ef7\u683c\u6307\u6570\uff08CPI\uff09\u518d\u6b21\u4e0d\u5982\u4eba\u610f\uff0c\u533a\u57df\u94f6\u884c\u80a1\u7968\u7684\u6ce2\u52a8\u52a0\u5927\uff0c\u4f46\u6574\u4f53\u6765\u8bf4\uff0c\u7f8e\u56fd\u80a1\u5e02\u7684\u6210\u957f\u578b\u80a1\u7968\u672c\u5468\u4f9d\u7136\u7ef4\u6301 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":451608,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[455,747,925,459],"class_list":["post-460453","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-455","tag-747","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/460453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=460453"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/460453\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/451608"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=460453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=460453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=460453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}